Jeffrey Ives

Venture Partner, New York, NY
jeff@nlvpartners.com
646-871-6400

 

Jeff Ives joined New Leaf as a Venture Partner focused on the biopharmaceutical arena in January 2017.  Jeff Ives is an entrepreneur and CEO with over 30 years of experience building successful research organizations and delivering important new clinical candidates and products.  He serves as an independent director on four biotechnology companies and consults with multiple small biotech and midsize pharmas, reviewing ongoing internal programs, identifying new research programs and external collaborations, and performing scientific due diligences for clients primarily in the areas of medicinal chemistry, drug metabolism and preclinical development.
Jeff has extensive senior R&D leadership and scientific experience.  Jeff served as CEO of Satori Pharmaceuticals, a neurodegenerative disease company focused on discovery and development of breakthrough therapies for the treatment and prevention of Alzheimer’s disease.  He built a vibrant biotechnology start-up by raising over $40M of financing and building a strong team of talented scientists, world-class advisors and an experienced board of directors.
Prior to Satori, he served as a Senior Vice President at Pfizer, leading the neurodegenerative diseases, psychiatry and pain research areas and maximizing the impact of drug metabolism on global research and development programs. Jeff received his master and doctoral degrees in chemistry from Yale in and his bachelor degree from Colgate University.

Board Seats and Investments